You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 245 No. 19, May 15, 1981 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effect of Methoxsalen Photochemotherapy on Cost of Treatment for Psoriasis

An Example of Technological Assessment

Robert S. Stern, MD; Lawrence A. Thibodeau, PhD; Ruth A. Kleinerman, MPH; John A. Parrish, MD; Thomas B. Fitzpatrick, MD; Howard L. Bleich, MD

JAMA. 1981;245(19):1913-1918.


Abstract

In 1974 a new therapy that employs methoxsalen and ultraviolet A irradiation (PUVA) was introduced as an outpatient treatment for severe psoriasis. To study the effect of this therapy on the cost of treatment, we documented for 1,320 patients two major components of cost—hospitalization and PUVA treatments. When the one-year period before initiation of PUVA therapy was compared with a one-year period after initiation of PUVA therapy, average hospital days per person per year declined 77% (5.1 vs 1.2). This decrease in hospitalization was most notable among patients who continued to use PUVA therapy. Largely offsetting the reduction in cost from reduced hospitalization was the cost of PUVA treatments. Our data confirm the previously known effectiveness of PUVA therapy, and they provide no support for the hypothesis that PUVA substantially increases the cost of treating patients with severe psoriasis.

(JAMA 1981;245:1913-1918)



Author Affiliations

From the Departments of Dermatology, Massachusetts General Hospital, Beth Israel Hospital, and Harvard Medical School (Drs Stern, Parrish, and Fitzpatrick, and Ms Kleinerman), the Center for the Analysis of Health Practices (Drs Stern and Thibodeau) and Department of Biostatistics (Dr Thibodeau), Harvard School of Public Health, and the Computer Medicine Laboratory (Dr Bleich) and Department of Medicine (Drs Stern and Bleich), Beth Israel Hospital and Harvard Medical School, Boston.


Footnotes

Reprint requests to Department of Dermatology, Beth Israel Hospital, 330 Brookline Ave, Boston (Dr Stern).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.